Improvement of von Willebrand Factor Proteolysis After Prostacyclin Infusion in Severe Pulmonary Arterial Hypertension
- 14 November 2000
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 102 (20), 2460-2462
- https://doi.org/10.1161/01.cir.102.20.2460
Abstract
Background—The presence of dysfunctional von Willebrand factor (vWF) in pulmonary arterial hypertension (PAH) was suggested to be related to increased proteolysis. Methods and Results—In 10 patient...Keywords
This publication has 15 references indexed in Scilit:
- Estimation of the von Willebrand Factor-cleaving Protease in Plasma Using Monoclonal Antibodies to vWFThrombosis and Haemostasis, 1999
- Laboratory diagnosis of von Willebrand diseaseInternational Journal of Clinical and Laboratory Research, 1998
- Antibodies to von Willebrand Factor–Cleaving Protease in Acute Thrombotic Thrombocytopenic PurpuraNew England Journal of Medicine, 1998
- von Willebrand Factor–Cleaving Protease in Thrombotic Thrombocytopenic Purpura and the Hemolytic–Uremic SyndromeNew England Journal of Medicine, 1998
- Circulating von Willebrand Factor Antigen as a Predictor of Short-term Prognosis in Pulmonary HypertensionChest, 1998
- Primary Pulmonary HypertensionNew England Journal of Medicine, 1997
- Shear stress enhances the proteolysis of von Willebrand factor in normal plasmaBlood, 1994
- Circulating Platelet Aggregates Indicative of in Vivo Platelet Activation in Pulmonary HypertensionAngiology, 1993
- Endothelial Dysfunction in Pulmonary HypertensionNew England Journal of Medicine, 1992
- Human von Willebrand factor: a multivalent protein composed of identical subunitsBiochemistry, 1986